publication . Article . Other literature type . 2018

rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology

Alexander Hein; Melissa Kellar; Jacek Gronwald; Diether Lambrechts; Marc T. Goodman; Michelle A.T. Hildebrandt; Pamela J. Thompson; Malcolm C. Pike; Peter A. Fasching; Peter Hillemanns; ...
Open Access English
  • Published: 21 Aug 2018
Abstract
95% CI = 1.03–1.24
Subjects
free text keywords: consortia, enolase superfamily member 1, expression quantitative trait locus, genetics, gynecology, ovarian neoplasms, single-nucleotide polymorphism, thymidylate synthase, CANCER ASSOCIATION CONSORTIUM, CARBON TRANSFER PATHWAY, SYNTHASE MESSENGER-RNA, DIFFERENT HISTOTYPES, SUSCEPTIBILITY LOCI, CIGARETTE-SMOKING, GENETIC-VARIATION, METAANALYSIS, EXPRESSION, 3122 Cancers, 1182 Biochemistry, cell and molecular biology, Australian Ovarian Cancer Study Group, Ovarian Cancer Association Consortium, Humans, Adenocarcinoma, Mucinous, Hydro-Lyases, Proteins, RNA, Antisense, Logistic Models, Odds Ratio, Risk, Case-Control Studies, Signal Transduction, Gene Expression Regulation, Neoplastic, Polymorphism, Single Nucleotide, Quantitative Trait Loci, Middle Aged, Female, Genetic Association Studies, Article, Other Chemical Sciences, Other Biological Sciences, Chemical Physics, Biology (General), QH301-705.5, Chemistry, QD1-999, 0399 Other Chemical Sciences, 0604 Genetics, 0699 Other Biological Sciences, /dk/atira/pure/researchoutput/pubmedpublicationtype/D016428, Journal Article, /dk/atira/pure/researchoutput/pubmedpublicationtype/D017418, Meta-Analysis, Consortia, enolase superfamily member 1, expression quantitative trait locus, genetics, gynecology, ovarian neoplasms, single-nucleotide polymorphism, thymidylate synthase, Case-control study, Polymorphism (computer science), Oncology, medicine.medical_specialty, medicine, biology.protein, biology, Adenocarcinoma, medicine.disease, Internal medicine, Expression quantitative trait loci, Ovarian carcinoma
Funded by
NIH| Core--Tissue Banking and Pathology
Project
  • Funder: National Institutes of Health (NIH)
  • Project Code: 5P50CA105009-02
  • Funding stream: NATIONAL CANCER INSTITUTE
,
NIH| COLLABORATIVE STUDY OF OVARIAN CANCER IN TWO RISK GROUPS
Project
  • Funder: National Institutes of Health (NIH)
  • Project Code: 5R01CA058598-05
  • Funding stream: NATIONAL CANCER INSTITUTE
,
NIH| Life Course Cancer Epidemiology Cohort in Women
Project
  • Funder: National Institutes of Health (NIH)
  • Project Code: 1UM1CA176726-01
  • Funding stream: NATIONAL CANCER INSTITUTE
,
NIH| OVARIAN CANCER RISK AND SURVIVAL IN BRCA CARRIERS
Project
  • Funder: National Institutes of Health (NIH)
  • Project Code: 5K07CA080668-06
  • Funding stream: NATIONAL CANCER INSTITUTE
,
NIH| Cancer Risk Reduction and Diet: A Cohort Study of Women
Project
  • Funder: National Institutes of Health (NIH)
  • Project Code: 2R37CA070867-12
  • Funding stream: NATIONAL CANCER INSTITUTE
16 references, page 1 of 2

10. Kelemen, L.E.; Goodman, M.T.; McGuire, V.; Rossing, M.A.; Webb, P.M.; Kobel, M.; Anton-Culver, H.; Beesley, J.; Berchuck, A.; Brar, S.; et al. Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium. Cancer Epidemiol. Biomark. Prev. 2010, 19, 1822-1830. [CrossRef] [PubMed] [OpenAIRE]

11. Dolnick, B.J. Cloning and characterization of a naturally occurring antisense RNA to human thymidylate synthase mRNA. Nucleic Acids Res. 1993, 21, 1747-1752. [CrossRef] [PubMed] [OpenAIRE]

12. Dolnick, B.J.; Black, A.R.; Winkler, P.M.; Schindler, K.; Hsueh, C.T. rTS gene expression is associated with altered cell sensitivity to thymidylate synthase inhibitors. Adv. Enzym. Regul. 1996, 36, 165-180. [CrossRef]

13. Chu, J.; Dolnick, B.J. Natural antisense (rTSalpha) RNA induces site-specific cleavage of thymidylate synthase mRNA. Biochim. Biophys. Acta 2002, 1587, 183-193. [CrossRef] [OpenAIRE]

14. Vogelstein, B.; Fearon, E.R.; Hamilton, S.R.; Kern, S.E.; Preisinger, A.C.; Leppert, M.; Nakamura, Y.; White, R.; Smits, A.M.; Bos, J.L. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 1988, 319, 525-532. [CrossRef] [PubMed]

15. Marquez, R.T.; Baggerly, K.A.; Patterson, A.P.; Liu, J.; Broaddus, R.; Frumovitz, M.; Atkinson, E.N.; Smith, D.I.; Hartmann, L.; Fishman, D.; et al. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Clin. Cancer Res. 2005, 11, 6116-6126. [CrossRef] [PubMed]

16. Heinzelmann-Schwarz, V.A.; Gardiner-Garden, M.; Henshall, S.M.; Scurry, J.P.; Scolyer, R.A.; Smith, A.N.; Bali, A.; Vanden Bergh, P.; Baron-Hay, S.; Scott, C.; et al. A distinct molecular profile associated with mucinous epithelial ovarian cancer. Br. J. Cancer 2006, 94, 904-913. [CrossRef] [PubMed]

17. Auersperg, N.; Wong, A.S.; Choi, K.C.; Kang, S.K.; Leung, P.C. Ovarian surface epithelium: Biology, endocrinology, and pathology. Endocr. Rev. 2001, 22, 255-288. [CrossRef] [PubMed] [OpenAIRE]

18. Tavassoulu, F.A.; Devilee, P. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Breast and Female Genital Organs; IARC Press: Lyon, France, 2003.

19. Wang, K.K.; Sampliner, R.E. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am. J. Gastroenterol. 2008, 103, 788-797. [CrossRef] [PubMed] [OpenAIRE]

20. Pharoah, P.D.; Tsai, Y.Y.; Ramus, S.J.; Phelan, C.M.; Goode, E.L.; Lawrenson, K.; Buckley, M.; Fridley, B.L.; Tyrer, J.P.; Shen, H.; et al. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat. Genet. 2013, 45, 362-370e2. [CrossRef] [PubMed]

21. Sakoda, L.C.; Jorgenson, E.; Witte, J.S. Turning of COGS moves forward findings for hormonally mediated cancers. Nat. Genet. 2013, 45, 345-348. [CrossRef] [PubMed] [OpenAIRE]

22. GTEx Consortium. Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans. Science 2015, 348, 648-660. [CrossRef] [PubMed]

23. Konecny, G.E.; Wang, C.; Hamidi, H.; Winterhoff, B.; Kalli, K.R.; Dering, J.; Ginther, C.; Chen, H.W.; Dowdy, S.; Cliby, W.; et al. Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancer. J. Natl. Cancer Inst. 2014, 106. [CrossRef] [PubMed] [OpenAIRE]

24. Higgins, J.P.; Thompson, S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 2002, 21, 1539-1558. [CrossRef] [PubMed]

16 references, page 1 of 2
Any information missing or wrong?Report an Issue